HSK55718 clinical trials
How each study uses HSK55718 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the HSK55718 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- HSK55718 dose level 3
- 2
By phase
A phase 1/2 study counts in both.
- Phase 2
- 3
Who runs them
Industry 2 · Other 1
Haisco Pharmaceutical Group Co., Ltd. (2) · Yingyong Zhou,MD,PhD (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test HSK55718.
- Nov 2026A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Orthopedic SurgeryPhase 2 · Haisco Pharmaceutical Group Co., Ltd.
- Nov 2026A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Abdominal SurgeryPhase 2 · Haisco Pharmaceutical Group Co., Ltd.
Studies
Open first, then newest update. How each study uses HSK55718 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Phase II Clinical Study of the Efficacy and Safety of HSK55718 in the Treatment of Abdominal Postoperative PainRecruitingPhase 2Yingyong Zhou,MD,PhDNCT07491146Written as Low dose HSK55718
- A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Abdominal SurgeryRecruitingPhase 2Haisco Pharmaceutical Group Co., Ltd.NCT07533786Written as HSK55718 dose level1
- A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Orthopedic SurgeryNot yet recruitingPhase 2Haisco Pharmaceutical Group Co., Ltd.NCT07551739Written as HSK55718 dose level 1